Author + information
- Yevgeniy Khariton,
- Jingyan Wang,
- Krishna Patel,
- Paul Chan,
- John Spertus and
- Kim Smolderen
Background: Recent guidelines recommend that patients with peripheral arterial disease (PAD) be treated with a moderate to high intensity statin. However, it is unknown the extent to which patients presenting with outpatient PAD symptoms (new or worsening) are offered guideline-directed statin therapy after evaluation.
Methods: In the international PORTRAIT PAD registry, guideline-recommended moderate to high intensity statin treatment was evaluated before and after PAD evaluation in 1203 patients from 16 PAD clinics in the US, the Netherlands, and Australia. Statin treatment was categorized as no statin, low, moderate, or high intensity statin before and after outpatient PAD evaluation. Statin prescriptions and potencies before and after evaluation were quantified. Proportions of patients on guideline-directed statin therapy after evaluation were determined.
Results: Overall, 864 (72%) patients were treated with a statin. Among 1203 patients with data on statin intensity, 910 (76%) were treated with a statin of at least moderate intensity statin. Notably, only 30% of patients not on statins initially and 0.0% of patients on a low-intensity statin at baseline had initiation or intensification to at least a moderate intensity statin after outpatient PAD evaluation.
Conclusions: One out of 5 patients with new or an exacerbation of PAD symptoms do not receive guideline-recommended statin therapy, and many patients on no or low intensity statins at baseline remained sub-optimally treated.
Room 209 C
Saturday, March 18, 2017, 9:17 a.m.-9:27 a.m.
Session Title: Highlighted Original Research: Vascular Medicine and the Year in Review
Abstract Category: 40. Vascular Medicine: Non Coronary Arterial Disease
Presentation Number: 905-14
- 2017 American College of Cardiology Foundation